|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Higashi T and Kurokawa Y: Incidence,
mortality, survival, and treatment statistics of cancers in
digestive organs-Japanese cancer statistics 2024. Ann Gastroenterol
Surg. 8:958–965. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Janjigian YY, Shitara K, Moehler M,
Garrido M, Salman P, Shen L, Wyrwicz L, Yamaguchi K, Skoczylas T,
Campos Bragagnoli A, et al: First-line nivolumab plus chemotherapy
versus chemotherapy alone for advanced gastric, gastro-oesophageal
junction, and oesophageal adenocarcinoma (CheckMate 649): A
randomised, open-label, phase 3 trial. Lancet. 389:27–40. 2021.
View Article : Google Scholar
|
|
4
|
Rha SY, Oh DY, Yañez P, Bai Y, Ryu MH, Lee
J, Rivera F, Alves GV, Garrido M, Shiu KK, et al: Pembrolizumab
plus chemotherapy versus placebo plus chemotherapy for
HER2-negative advanced gastric cancer (KEYNOTE-859): A multicentre,
randomised, double-blind, phase 3 trial. Lancet Oncol.
24:1181–1195. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rosa F, Schena CA, Laterza V, Quero G,
Fiorillo C, Strippoli A, Pozzo C, Papa V and Alfieri S: The role of
surgery in the management of gastric cancer: State of the art.
Cancers (Basel). 14:55422022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shimada H, Fukagawa T, Haga Y and Oba K:
Does postoperative morbidity worsen the oncological outcome after
radical surgery for gastrointestinal cancers? A systematic review
of the literature. Ann Gastroenterol Surg. 1:11–23. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tsujimoto H, Ichikura T, Ono S, Sugasawa
H, Hiraki S, Sakamoto N, Yaguchi Y, Yoshida K, Matsumoto Y and Hase
K: Impact of postoperative infection on long-term survival after
potentially curative resection for gastric cancer. Ann Surg Oncol.
16:311–318. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yaguchi Y, Tsujimoto H, Kumano I, Takahata
R, Matsumoto Y, Yoshida K, Horiguchi H, Ono S, Ichikura T, Yamamoto
J and Hase K: Sentinel node navigation surgery attenuates the
functional disorders in early gastric cancer. Oncol Rep.
27:643–649. 2012.PubMed/NCBI
|
|
9
|
Badia JM, Casey AL, Petrosillo N, Hudson
PM, Mitchell SA and Crosby C: Impact of surgical site infection on
healthcare costs and patient outcomes: A systematic review in six
European countries. J Hosp Infect. 96:1–15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kusachi S, Kashimura N, Konishi T, Shimizu
J, Kusunoki M, Oka M, Wakatsuki T, Kobayashi J, Sawa Y, Imoto H, et
al: Length of stay and cost for surgical site infection after
abdominal and cardiac surgery in Japanese hospitals: Multi-center
surveillance. Surg Infect (Larchmt). 13:257–265. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tsujimoto H, Kouzu K, Sugasawa H, Nomura
S, Ito N, Harada M, Sugihara T, Ishibashi Y, Kishi Y and Ueno H:
Impact of postoperative infectious complications on adjuvant
chemotherapy administration after gastrectomy for advanced gastric
cancer. Jpn J Clin Oncol. 51:379–386. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matsuda A, Maruyama H, Akagi S, Inoue T,
Uemura K, Kobayashi M, Shiomi H, Watanabe M, Fujita T, Takahata R,
et al: Survival impact of surgical site infection in esophageal
cancer surgery: A multicenter retrospective cohort study. Ann
Gastroenterol Surg. 7:603–614. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsujimoto H, Ueno H, Hashiguchi Y, Ono S,
Ichikura T and Hase K: Postoperative infections are associated with
adverse outcome after resection with curative intent for colorectal
cancer. Oncol Lett. 1:119–125. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ueno H and Tsujimoto H: Postoperative
complications and impaired Long-term survival-Is this causation or
association? Ann Gastroenterol Surg. 7:5–6. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saklad M: Grading of patients for surgical
procedures. Anesthesiology. 2:281–284. 1941. View Article : Google Scholar
|
|
16
|
Kouzu K, Tsujimoto H, Nagata H, Sugasawa
H, Ishibashi Y, Hase K, Kishi Y and Ueno H: Preoperative fall risk
assessment score as a prognostic factor in gastric cancer patients
after gastrectomy. Jpn J Clin Oncol. 51:569–576. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Makary MA, Segev DL, Pronovost PJ, Syin D,
Bandeen-Roche K, Patel P, Takenaga R, Devgan L, Holzmueller CG,
Tian J and Fried LP: Frailty as a predictor of surgical outcomes in
older patients. J Am Coll Surg. 210:901–908. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fukuda Y, Yamamoto K, Hirao M, Nishikawa
K, Nagatsuma Y, Nakayama T, Tanikawa S, Maeda S, Uemura M, Miyake
M, et al: Sarcopenia is associated with severe postoperative
complications in elderly gastric cancer patients undergoing
gastrectomy. Gastric Cancer. 19:986–993. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nagata K, Tsujimoto H, Nagata H, Harada M,
Ito N, Kanematsu K, Nomura S, Horiguchi H, Hiraki S, Hase K, et al:
Impact of reduced skeletal muscle volume on clinical outcome after
esophagectomy for esophageal cancer: A retrospective study.
Medicine (Baltimore). 97:e114502018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takano Y, Haruki K, Kai W, Tsukihara S,
Kobayashi Y, Ito D, Kanno H, Son K, Hanyu N and Eto K: The
influence of serum cholinesterase levels and sarcopenia on
postoperative infectious complications in colorectal cancer
surgery. Surg Today. 53:816–823. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu H and Kong F: Malnutrition-related
factors increased the risk of anastomotic leak for rectal cancer
patients undergoing surgery. Biomed Res Int. 2020:50596702020.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Charlson ME, Pompei P, Ales KL and
MacKenzie CR: A new method of classifying prognostic comorbidity in
longitudinal studies: Development and validation. J Chronic Dis.
40:373–383. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bilgin B, Sendur MA, Bulent Akinci M,
Sener Dede D and Yalcin B: Targeting the PD-1 pathway: A new hope
for gastrointestinal cancers. Curr Med Res Opin. 33:749–759. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kang YK, Boku N, Satoh T, Ryu MH, Chao Y,
Kato K, Chung HC, Chen JS, Muro K, Kang WK, et al: Nivolumab in
patients with advanced gastric or gastro-oesophageal junction
cancer refractory to, or intolerant of, at least two previous
chemotherapy regimens (ONO-4538-12, ATTRACTION-2): A randomised,
double-blind, placebo-controlled, phase 3 trial. Lancet.
390:2461–2471. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Muro K, Chung HC, Shankaran V, Geva R,
Catenacci D, Gupta S, Eder JP, Golan T, Le DT, Burtness B, et al:
Pembrolizumab for patients with PD-L1-positive advanced gastric
cancer (KEYNOTE-012): A multicentre, open-label, phase 1b trial.
Lancet Oncol. 17:717–726. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shimada Y, Hayashi M, Nagasaka Y,
Ohno-Iwashita Y and Inomata M: Age-associated up-regulation of a
negative co-stimulatory receptor PD-1 in mouse CD4+ T cells. Exp
Gerontol. 44:517–522. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Association JGC: Japanese classification
of gastric carcinoma: 3rd English edition. Gastric Cancer.
14:101–112. 2011. View Article : Google Scholar
|
|
28
|
Dindo D, Demartines N and Clavien PA:
Classification of surgical complications: A new proposal with
evaluation in a cohort of 6336 patients and results of a survey.
Ann Surg. 240:205–213. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ito N, Tsujimoto H, Miyazaki H, Takahata R
and Ueno H: Pivotal role of myeloid-derived suppressor cells in
infection-related tumor growth. Cancer Med. 13:e69172024.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ishibashi Y, Tsujimoto H, Hiraki S, Kumano
I, Yaguchi Y, Horiguchi H, Nomura S, Ito N, Shinto E, Aosasa S, et
al: Prognostic value of preoperative systemic immunoinflammatory
measures in patients with esophageal cancer. Ann Surg Oncol.
25:3288–3299. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Onodera T, Goseki N and Kosaki G:
Prognostic nutritional index in gastrointestinal surgery of
malnourished cancer patients. Nihon Geka Gakkai Zasshi.
85:1001–1005. 1984.(In Japanese). PubMed/NCBI
|
|
32
|
Ignacio de Ulibarri J, Gonzalez-Madrono A,
de Villar NG, González P, González B, Mancha A, Rodríguez F and
Fernández G: CONUT: A tool for controlling nutritional status.
First validation in a hospital population. Nutr Hosp. 20:38–45.
2005.PubMed/NCBI
|
|
33
|
Murthy BL, Thomson CS, Dodwell D, Shenoy
H, Mikeljevic JS, Forman D and Horgan K: Postoperative wound
complications and systemic recurrence in breast cancer. Br J
Cancer. 97:1211–1217. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tsujimoto H, Kobayashi M, Sugasawa H, Ono
S, Kishi Y and Ueno H: Potential mechanisms of tumor progression
associated with postoperative infectious complications. Cancer
Metastasis Rev. 40:285–296. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tan ZK, Tang WZ, Jia K, Li DN, Qiu LY,
Chen X and Yang L: Relation between frailty and adverse outcomes in
elderly patients with gastric cancer: A scoping review. Ann Med
Surg (Lond). 86:1590–1600. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Matsui R, Inaki N and Tsuji T: Impact of
preoperative muscle quality on postoperative severe complications
after radical gastrectomy for gastric cancer patients. Ann
Gastroenterol Surg. 5:510–518. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Joharatnam-Hogan N, Shiu KK and Khan K:
Challenges in the treatment of gastric cancer in the older patient.
Cancer Treat Rev. 85:1019802020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Khoury SJ and Sayegh MH: The roles of the
new negative T cell costimulatory pathways in regulating
autoimmunity. Immunity. 20:529–538. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Channappanavar R, Twardy BS, Krishna P and
Suvas S: Advancing age leads to predominance of inhibitory receptor
expressing CD4 T cells. Mech Ageing Dev. 130:709–712. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Foldi J, Kozhaya L, McCarty B, Mwamzuka M,
Marshed F, Ilmet T, Kilberg M, Kravietz A, Ahmed A, Borkowsky W, et
al: HIV-infected children have elevated levels of PD-1+ memory CD4
T cells with low proliferative capacity and high inflammatory
cytokine effector functions. J Infect Dis. 216:641–650. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Deng M, Zeng Y, Liu Y, Wang X, Chen N,
Zhang M, Jiang M, Zhao H and Du J: Increased PD-1+ NK cell subset
in the older population. Int J Gen Med. 17:651–661. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ono S, Aosasa S, Tsujimoto H, Ueno C and
Mochizuki H: Increased monocyte activation in elderly patients
after surgical stress. Eur Surg Res. 33:33–38. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang J, Pei L, Zhao T, Liu X, Wang Q,
Zhang S, Li J, Wu H and Niu D: CD4+ T cells related to
disease severity in elderly and frailty community-acquired
pneumonia patients: A retrospective cohort study. Immun Inflamm
Dis. 11:e10092023. View Article : Google Scholar : PubMed/NCBI
|
